Indonesian Journal of Cancer Chemoprevention
Vol 14, No 1 (2023)

Bioinformatics Analysis of Inhibition Activation SHP-2 by Galangal as Activating Agent of Cancer Immunotherapy

Maria Indra Ardriyanto (Faculty of Pharmacy, Universitas Gadjah Mada)
Faaza Aulia Rahman (Faculty of Pharmacy, Universitas Gadjah Mada)
Hanaan Emilia Adi Hastuti (Faculty of Pharmacy, Universitas Gadjah Mada)
Edy Meiyanto (Faculty of Pharmacy, Universitas Gadjah Mada)
Taro Kawai (Lab. of Imunobiology Molecular, School of Biosciences, Nara Institute of Science and Technology, Japan)
Dyaningtyas Dewi Pamungkas Putri (Faculty of Pharmacy, Universitas Gadjah Mada)



Article Info

Publish Date
30 May 2023

Abstract

Interleukin 12 (IL-12) is a pro-inflammatory cytokine type 1 that has acted as a potential immunotherapy for cancer. The mechanism of IL-12 increases the activity of cytotoxic T cells and Natural Killer (NK) cells, reverse tumor-induced immunosuppression, prevent angiogenesis, and increases lymphocyte and antigen transport. Galangal is one of the natural ingredients that have biological activity as an anticancer and immunomodulator. In this research, researchers wanted to know the potential of the active compound of galangal to activate IL-12 by inhibiting the IL-12 analog, namely SHP-2. This research uses bioinformatics studies using several databases such as RCSB PDB, ChEMBL, Dr. Duke's Phytochemical and Ethnobotanical, UALCAN, OncoLnc and computational analysis using KNIME and MOE software. The SHP-2 structure used is taken from the RCSB PDB with the code 5EHR. The 10 compounds with the highest predictions of inhibiting SHP2 using KNIME were obtained, then molecular docking was performed using MOE and three compounds that had the potential to inhibit SHP-2 were Kaempferide, Galangin, and RiboflavinKeywords: cancer, computing, galangal, Interleukin 12, SHP-2.

Copyrights © 2023






Journal Info

Abbrev

ijcc

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Medicine & Pharmacology

Description

Indonesian Journal of Cancer Chemoprevention (IJCC) is an open access, peer-reviewed, triannual journal devoted to publishing articles on Cancer Chemoprevention including Experimental and Clinical Pharmacology, especially concerning Anti-Oxidants, Anti-Aging, Anti-Inflammation, Anti-Angiogenesis, ...